Home › Geographic Atrophy › Nevada
Geographic Atrophy clinical trials in Nevada
8 studies for Geographic Atrophy are looking for participants at sites in Nevada.
Cities in Nevada
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Sierra Eye Associates, Reno
RecruitingPhase 1/2
Ages 55 and older · All sexes · Updated Sep 23, 2026 · NCT07029945A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Sierra Eye Associates- Site Number : 8400021, Reno
RecruitingPhase 1/2
Ages 60 and older · All sexes · Updated Sep 22, 2026 · NCT07215234A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- Sierra Eye Associates, Reno
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Sep 15, 2026 · NCT05626114A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Sierra Eye Associates, Reno
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 14, 2026 · NCT06635148Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Sierra Eye Associates, Reno
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- Sierra Eye Associates, Reno
RecruitingObservational study
Ages 55 and older · All sexes · Updated Sep 3, 2026 · NCT07144137Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Sierra Eye Associates, Reno
Recruiting
Ages 60 and older · All sexes · Updated Aug 26, 2026 · NCT06662162Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Sierra Eye Associates /ID# 262142, Reno
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Jul 13, 2026 · NCT07160179From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.